CAPS News Alert Capstone Therapeutics Corp (CAPS) 0.2650 09/27/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 27, 2014 at 9:56 PM

Capstone Therapeutics Corp (CAPS) 0.2650 $CAPS

Capstone Therapeutics Corp. Announces Digital Corporate Communication Channels
GlobeNewswire - Fri Sep 05, 12:09PM CDT
Capstone Therapeutics Corp. (OTCQB:CAPS) (the "Company" or "Capstone Therapeutics"

, a clinical stage biotechnology company developing a family of new peptide drugs, announced today its suite of online corporate communication channels to maintain on-going direct communication with stakeholders. The Company has launched official portals on social media channels including Facebook, Twitter, Google+ and The Chairman's Blog.

Capstone Therapeutics, Inc. - "A New Class of Cardiovascular Drug"
ACCESSWIRE - Fri Sep 05, 7:48AM CDT
New York, NY / September 5, 2014 / Capstone Therapeutics (OTCQB: CAPS) today published a new blog post on The Chairman's Blog, written by the Company's Executive Chairman and Principal Executive Officer, Jock Holliman. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Capstone Therapeutics Announces Phase 1a Results for AEM-28 Showing Safety and Biomarker Efficacy Signals
GlobeNewswire - Tue Sep 02, 8:57AM CDT
Capstone Therapeutics (OTCQB:CAPS) ("the Company"

and its joint venture affiliate, LipimetiX Development, LLC ("JV"

, announced today the completion of dosing and patient follow-up for its investigational AEM-28 (Apo E mimetic peptide) Phase 1a human clinical trial in cholesterol and lipid reduction. The Medical Safety Committee, reviewing all safety-related aspects of the clinical trial, observed an acceptable safety profile. As a first-in-man study, the primary endpoint was safety; yet, biomarker efficacy measurements analyzing pharmacodynamics yielded trends favoring AEM-28 versus placebo in multiple cholesterol and lipid endpoints.

Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 14, 8:05AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, today will hold a conference call and webcast to provide an operating update and announced financial results for the second quarter 2014.

Capstone Therapeutics Announces Second Quarter 2014 Financial Results and Operating Update Conference Call
GlobeNewswire - Wed Aug 06, 9:00AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Thursday, August 14, 2014 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning August 14, 2014 at 7:30 pm EDT until midnight August 17, 2014, and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 81563431.

Capstone Therapeutics Announces Operating Update Conference Call, Planned Initiation of AEM-28 Phase 1 Study and Fiscal Year 2013 Financial Results
GlobeNewswire - Thu Mar 27, 9:29AM CDT
Capstone Therapeutics (OTCQB:CAPS) ("the Company"

and its joint venture affiliate, LipimetiX Development, LLC ("JV"

, today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013.

Capstone Therapeutics Announces Operating Update Conference Call
GlobeNewswire - Mon Mar 24, 1:30PM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning March 27, 2014 at 7:30 pm EDT until midnight March 30, 2014, and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 12618657.

Health Briefs TV to Feature QAL Medical
PRWeb - Thu Jan 16, 12:01PM CST
The producers of Health Briefs TV are pleased to announce that QAL Medical will be featured in an upcoming segment on topics, trends, and issues related to "Improving Therapy Outcomes through Effective Technology Solutions" as part of the show's "Healthcare Today" series.

OTC Daily Alert Stock Watch - Capstone Therapeutics (OTCQB: CAPS)
WorldStockWire - Thu Aug 15, 9:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Capstone Therapeutics to Hold Quarterly Operating Update Conference Call
GlobeNewswire - Wed Aug 07, 1:16PM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Wednesday, August 14, 2013 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning August 14, 2013 at 7:30 pm EDT until midnight August 17, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 27383573.

Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results
GlobeNewswire - Wed May 15, 8:30AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, today will hold a conference call and webcast to provide an operating update and announced financial results for the first quarter 2013.

Capstone Therapeutics to Hold Operating Update Conference Call
GlobeNewswire - Wed May 08, 8:00AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, will hold a conference call and webcast on Wednesday, May 15, 2013 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning May 15, 2013 at 7:30 pm EDT until midnight May 18, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 68894502.

Capstone Therapeutics Will Provide an Operating Update and Announces 2012 Financial Results
GlobeNewswire - Thu Mar 14, 7:15AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company"

, today will hold a conference call and webcast to provide an operating update and 2012 financial results.

OTC Signal Daily Stock Watch - Capstone Therapeutics (CAPS)
WorldStockWire - Mon Dec 17, 10:45AM CST
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Claigan Webinar Tackles Prop 65 Warnings for 2028

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Class Action Lawsuit Hits Desert Resort Management

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Kansas Marijuana DUI Laws: What Drivers Must Know

Navigating the Legal Maze of Marijuana DUIs Marijuana DUI, ever heard of it? Many folks in Kansas might just find themselves scratching their heads. While booze clearly shouts 'DUI' when you hit the road sauced, the green stuff doesn’t dodge that same bullet. You better believe it, Kansas doesn’t mess around when it comes to drugs behind the wheel, and marijuana is...

LifeLabs' AI Program: A Manager's New Toolbox

Management In the Age of AI: New Frontiers Gone are the days when a simple software update meant staying competitive. We're in a new era, folks—one where AI isn't just a handy tool—it's reshaping entire industries. But here's the kicker: all the fancy tech in the world won't do squat without savvy managers who know how to drive adoption. Yup, that's the naked truth,...

BLM's Wild Horse Strategy: Fertility Control's Time to Shine

Wild Horse Management Gets a Shot in the Arm Amigo, when the federal government throws $30 million dollars at a problem, you'd hope they're not just throwing us a bone. The Bureau of Land Management (BLM) now has this hefty sum courtesy of the U.S. Department of Agriculture, intended to expand wild horse fertility control across the sprawling landscapes they roam. This...

Klydoclock's Bold Move: Licensing International Boost

Revolutionizing Timekeeping with Art There’s this clock outfit, Klydoclock, that’s flipping the script on how we see time and art melding together. You see, they’ve taken those static old tick-tock reminders of the hour and juiced 'em up with animated art, turning your wall clock into something more akin to a mini art exhibit right in your living room. Ever heard of...

Alito's Recusal: Supreme Court Climate Case Shaker

Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...

Derek Pesta Shines: Forbes Top Wealth Advisors 2026

An Unwavering Dedication to Clients Every once in a while, the industry tips its hat to someone who truly knows what they're doing. Derek Pesta, head honcho at Pesta & Pesta Wealth Management, has landed on the 2026 Forbes Top Next-Gen Wealth Advisors Best-in-State list. It’s not just a pat on the back; it's a solid nod to the way he runs his game. You know it’s big...

Celina Graves Joins Expanding GoLive Streamers Platform

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

Nailah Thorbourne's Vlair Shapewear: Fashion Freedom

Fashion with a Punch: Nailah Thorbourne's New Venture You'd think from the way the fashion industry's been humming along that someone would've cracked the code on shapewear a long time ago, right? But alas, it takes Nailah Thorbourne to step out of Brick & Lace's spotlight and into this shapely market with Vlair Shapewear. Apparently, what most overlooked in comfort, she...